Literature DB >> 17581170

Standards for the terminology and labeling of cellular therapy products.

Paul Ashford1, Pat Distler, Adrian Gee, Alan Lankester, Stella Larsson, Irene Feller, Kathy Loper, Derwood Pamphilon, Leigh Poston, Fran Rabe, Ineke Slaper-Cortenbach, Zbigniew Szczepiorkowski, Phyllis Warkentin.   

Abstract

Mesh：

Year:  2007        PMID： 17581170     DOI： 10.1111/j.1537-2995.2007.01389.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  4 in total

1.  Current Regulations for the Production of Multipotent Mesenchymal Stromal Cells for Clinical Application.

Authors:  Ineke C M Slaper-Cortenbach
Journal:  Transfus Med Hemother       Date:  2008-07-21       Impact factor: 3.747

2.  ISBT 128 coding and labeling for cellular therapy products.

Authors:  Ineke Slaper-Cortenbach
Journal:  Cell Tissue Bank       Date:  2010-09-21       Impact factor: 1.522

3.  ISBT 128: a global information standard.

Authors:  Pat Distler
Journal:  Cell Tissue Bank       Date:  2010-07-21       Impact factor: 1.522

Review 4.  ISBT 128 Standard for Coding Medical Products of Human Origin.

Authors:  Paul Ashford; Matthew Delgado
Journal:  Transfus Med Hemother       Date:  2017-11-20       Impact factor: 3.747
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.